List of Tables
    Table 1. Bile Duct Cancer Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Bile Duct Cancer Drugs Market Trends
    Table 3. Bile Duct Cancer Drugs Market Drivers
    Table 4. Bile Duct Cancer Drugs Market Challenges
    Table 5. Bile Duct Cancer Drugs Market Restraints
    Table 6. Global Bile Duct Cancer Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Bile Duct Cancer Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Bile Duct Cancer Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Bile Duct Cancer Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Bile Duct Cancer Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Bile Duct Cancer Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Bile Duct Cancer Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Bile Duct Cancer Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Bile Duct Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer Drugs as of 2021)
    Table 15. Top Players of Bile Duct Cancer Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Bile Duct Cancer Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Bile Duct Cancer Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Bile Duct Cancer Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Bile Duct Cancer Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Bile Duct Cancer Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Bile Duct Cancer Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Bile Duct Cancer Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Bile Duct Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Bile Duct Cancer Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Bile Duct Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Bile Duct Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Bile Duct Cancer Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Celgene Company Details
    Table 31. Celgene Business Overview
    Table 32. Celgene Bile Duct Cancer Drugs Product
    Table 33. Celgene Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 34. Celgene Recent Development
    Table 35. Mylan Company Details
    Table 36. Mylan Business Overview
    Table 37. Mylan Bile Duct Cancer Drugs Product
    Table 38. Mylan Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 39. Mylan Recent Development
    Table 40. Eli Lilly Company Details
    Table 41. Eli Lilly Business Overview
    Table 42. Eli Lilly Bile Duct Cancer Drugs Product
    Table 43. Eli Lilly Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 44. Eli Lilly Recent Development
    Table 45. Johnson & Johnson Company Details
    Table 46. Johnson & Johnson Business Overview
    Table 47. Johnson & Johnson Bile Duct Cancer Drugs Product
    Table 48. Johnson & Johnson Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 49. Johnson & Johnson Recent Development
    Table 50. Accord Healthcare Company Details
    Table 51. Accord Healthcare Business Overview
    Table 52. Accord Healthcare Bile Duct Cancer Drugs Product
    Table 53. Accord Healthcare Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 54. Accord Healthcare Recent Development
    Table 55. Roche Company Details
    Table 56. Roche Business Overview
    Table 57. Roche Bile Duct Cancer Drugs Product
    Table 58. Roche Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 59. Roche Recent Development
    Table 60. Teva Company Details
    Table 61. Teva Business Overview
    Table 62. Teva Bile Duct Cancer Drugs Product
    Table 63. Teva Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 64. Teva Recent Development
    Table 65. AbbVie Company Details
    Table 66. AbbVie Business Overview
    Table 67. AbbVie Bile Duct Cancer Drugs Product
    Table 68. AbbVie Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 69. AbbVie Recent Development
    Table 70. Bristol-Myers Squibb Company Details
    Table 71. Bristol-Myers Squibb Business Overview
    Table 72. Bristol-Myers Squibb Bile Duct Cancer Drugs Product
    Table 73. Bristol-Myers Squibb Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 74. Bristol-Myers Squibb Recent Development
    Table 75. Pfizer Company Details
    Table 76. Pfizer Business Overview
    Table 77. Pfizer Bile Duct Cancer Drugs Product
    Table 78. Pfizer Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 79. Pfizer Recent Development
    Table 80. Intercept Pharmaceuticals Company Details
    Table 81. Intercept Pharmaceuticals Business Overview
    Table 82. Intercept Pharmaceuticals Bile Duct Cancer Drugs Product
    Table 83. Intercept Pharmaceuticals Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 84. Intercept Pharmaceuticals Recent Development
    Table 85. Novartis Company Details
    Table 86. Novartis Business Overview
    Table 87. Novartis Bile Duct Cancer Drugs Product
    Table 88. Novartis Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 89. Novartis Recent Development
    Table 90. Sanofi Company Details
    Table 91. Sanofi Business Overview
    Table 92. Sanofi Bile Duct Cancer Drugs Product
    Table 93. Sanofi Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 94. Sanofi Recent Development
    Table 95. Kyowa Hakko Kirin Company Details
    Table 96. Kyowa Hakko Kirin Business Overview
    Table 97. Kyowa Hakko Kirin Bile Duct Cancer Drugs Product
    Table 98. Kyowa Hakko Kirin Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 99. Kyowa Hakko Kirin Recent Development
    Table 100. Delcath Systems Company Details
    Table 101. Delcath Systems Business Overview
    Table 102. Delcath Systems Bile Duct Cancer Drugs Product
    Table 103. Delcath Systems Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 104. Delcath Systems Recent Development
    Table 105. Fresenius Kabi Company Details
    Table 106. Fresenius Kabi Business Overview
    Table 107. Fresenius Kabi Bile Duct Cancer Drugs Product
    Table 108. Fresenius Kabi Revenue in Bile Duct Cancer Drugs Business (2017-2022) & (US$ Million)
    Table 109. Fresenius Kabi Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bile Duct Cancer Drugs Product Picture
    Figure 2. Global Bile Duct Cancer Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Bile Duct Cancer Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Bile Duct Cancer Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Bile Duct Cancer Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Bile Duct Cancer Drugs Market Share in Global 2017-2028
    Figure 7. Bile Duct Cancer Drugs Report Years Considered
    Figure 8. Product Picture of 5-Fluorouracil (5-FU)
    Figure 9. Product Picture of Gemcitabine
    Figure 10. Product Picture of Cisplatin
    Figure 11. Product Picture of Capecitabine
    Figure 12. Product Picture of Oxaliplatin
    Figure 13. Product Picture of Others
    Figure 14. Global Bile Duct Cancer Drugs Market Share by Type in 2022 & 2028
    Figure 15. Global Bile Duct Cancer Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Bile Duct Cancer Drugs Market Share by Type (2017-2028)
    Figure 17. United States Bile Duct Cancer Drugs Market Share by Type in 2022 & 2028
    Figure 18. United States Bile Duct Cancer Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Bile Duct Cancer Drugs Market Share by Type (2017-2028)
    Figure 20. Product Picture of Hospitals & Clinic
    Figure 21. Product Picture of Cancer Treatment Centers
    Figure 22. Product Picture of Others
    Figure 23. Global Bile Duct Cancer Drugs Market Share by Application in 2022 & 2028
    Figure 24. Global Bile Duct Cancer Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Bile Duct Cancer Drugs Market Share by Application (2017-2028)
    Figure 26. United States Bile Duct Cancer Drugs Market Share by Application in 2022 & 2028
    Figure 27. United States Bile Duct Cancer Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Bile Duct Cancer Drugs Market Share by Application (2017-2028)
    Figure 29. North America Bile Duct Cancer Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Bile Duct Cancer Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Bile Duct Cancer Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Bile Duct Cancer Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Bile Duct Cancer Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Bile Duct Cancer Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Celgene Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 58. Mylan Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 59. Eli Lilly Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 61. Accord Healthcare Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 62. Roche Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 63. Teva Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 64. AbbVie Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 66. Pfizer Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 67. Intercept Pharmaceuticals Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 68. Novartis Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 69. Sanofi Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 70. Kyowa Hakko Kirin Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 71. Delcath Systems Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 72. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Drugs Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed